The state of Colorado currently has 2 active clinical trials seeking participants for Narcolepsy research studies. These trials are conducted in various cities, including Denver, Aurora, Colorado Springs and Englewood.
Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)
Recruiting
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of MK-6552 in participants with Narcolepsy Type 1 (NT1). Part 1 will evaluate safety, tolerability, and PK of MK-6552 after administration of ascending doses in a single day to support a dose level decision for Part 2. Part 2 will investigate the PD of MK-6552 after single-day and multiple-day administration. Participants who complete Part 1 and demonstrate that they are able to tolera... Read More
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
06/20/2024
Locations: Delta Waves, Inc. ( Site 0008), Colorado Springs, Colorado
Conditions: Narcolepsy
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Recruiting
The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 and type 2 narcolepsy from previous parent studies, TAK-861-2001 (NCT05687903) and TAK-861-2002 (NCT05687916).
Gender:
All
Ages:
Between 16 years and 70 years
Trial Updated:
02/15/2024
Locations: Delta Waves LLC - Hunt - PPDS, Colorado Springs, Colorado
Conditions: Narcolepsy Type 1, Narcolepsy Type 2